FOR IMMEDIATE RELEASE:
Chapel Hill, NC – 29 April 2019 – Whitsell Innovations, Inc, Acquires Electronic Regulatory Publishing and Regulatory Consulting Services Firm, Pharmakey, LLC.
Premier medical and scientific writing firm, Whitsell Innovations (WI), Inc, is pleased to announce the acquisition of Pharmakey, LLC. Pharmakey is known for customer-centric electronic regulatory publishing and regulatory consulting services. With these complementary areas of expertise, this acquisition greatly expands WI’s capacity to provide strategic consulting services and full electronic submissions across global health authorities.
“We are thrilled to be able to add these services to the scope of our offerings to our clients,” says WI Founder and President, Robin Whitsell. “We see this as an opportunity to bridge our clients’ needs from regulatory decision-making to focused and impactful writing to compliant electronic submissions.”
This transaction combines Chapel Hill-headquartered WI with Durham-based Pharmakey. Using Lorenz docuBridge® software for electronic regulatory submissions, Pharmakey has been providing strategic publishing and regulatory consulting services to global clients since 2009. The combination of WI’s scientific writing acumen and Pharmakey’s electronic publishing capabilities further enhances WI’s expertise as a full‑service medical and scientific writing company.
ABOUT WHITSELL INNOVATIONS, INC.
WI is a WBENC-certified woman-owned, full-service medical and scientific writing company headquartered in Chapel Hill, North Carolina, providing clinical, nonclinical, and quality regulatory writing to global pharmaceutical, biotechnical, and medical device clients since 2006.
Contact: Connie Morris, Operations Manager: Connie.Morris@whitsellinnovations.com
This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the company’s control. Whitsell Innovations, Inc’s actual results, performance, or achievements could be materially different from those projected by these forward-looking statements. Given these risks and uncertainties, you are cautioned not to place undue reliance on the forward-looking statements.